ENvue Medical (FEED) Liabilities and Shareholders Equity (2014 - 2026)
ENvue Medical (FEED) reported Liabilities and Shareholders Equity of $39.9 million for Q1 2026, down 9.6% year-over-year from $44.1 million in Q1 2025, and down 3.05% on a QoQ basis from $41.1 million in Q4 2025.
ENvue Medical (FEED) has 13 years of Liabilities and Shareholders Equity data on file, last reported at $39.9 million in Q1 2026.
- Quarterly Liabilities and Shareholders Equity fell 9.6% year-over-year to $39.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $186.9 million (up 221.55% YoY) and the FY2025 annual result came in at $41.1 million, up 1033.2% from the prior year.
- Liabilities and Shareholders Equity fell to $39.9 million in Q1 2026 per FEED's latest filing, from $41.1 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $54.4 million in Q3 2025 and bottomed at $3.6 million in Q4 2024.
- The 5-year median for Liabilities and Shareholders Equity is $6.5 million (2022), against an average of $17.6 million.
- The widest annual swing landed in 2022, when Liabilities and Shareholders Equity tumbled 46.1%; it then jumped 1061.53% in 2025.
- Tracing FEED's Liabilities and Shareholders Equity over 5 years: stood at $5.9 million in 2022, then increased by 13.52% to $6.7 million in 2023, then plunged by 45.62% to $3.6 million in 2024, then soared by 1033.2% to $41.1 million in 2025, then dropped by 3.05% to $39.9 million in 2026.
- Per Business Quant, the three latest FEED Liabilities and Shareholders Equity figures stand at $39.9 million (Q1 2026), $41.1 million (Q4 2025), and $54.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 91.49 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 31.92 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 6.63 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 10.74 Bn |
| 10 | ENvue Medical | 2.97 Mn | 709,615.89 | -55,000.00 | 39.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.87 Mn |
| Dec 31, 2025 | 41.12 Mn |
| Sep 30, 2025 | 54.38 Mn |
| Jun 30, 2025 | 51.48 Mn |
| Mar 31, 2025 | 44.11 Mn |
| Dec 31, 2024 | 3.63 Mn |
| Sep 30, 2024 | 4.68 Mn |
| Jun 30, 2024 | 5.70 Mn |
| Mar 31, 2024 | 6.24 Mn |
| Dec 31, 2023 | 6.67 Mn |
| Sep 30, 2023 | 7.36 Mn |
| Jun 30, 2023 | 3.83 Mn |
| Mar 31, 2023 | 4.81 Mn |
| Dec 31, 2022 | 5.88 Mn |
| Sep 30, 2022 | 5.21 Mn |
| Jun 30, 2022 | 6.54 Mn |
| Mar 31, 2022 | 7.66 Mn |
| Dec 31, 2021 | 8.62 Mn |
| Sep 30, 2021 | 9.67 Mn |
| Jun 30, 2021 | 6.83 Mn |
| Mar 31, 2021 | 8.60 Mn |
| Dec 31, 2020 | 8.23 Mn |
| Sep 30, 2020 | 4.10 Mn |
| Jun 30, 2020 | 1.01 Mn |
| Mar 31, 2020 | 1.12 Mn |
| Dec 31, 2019 | 2.04 Mn |
| Sep 30, 2019 | 3.07 Mn |
| Jun 30, 2019 | 3.11 Mn |
| Mar 31, 2019 | 817,000.00 |
| Dec 31, 2018 | 1.58 Mn |
| Mar 31, 2018 | 3.98 Mn |
| Dec 31, 2017 | 4.87 Mn |
| Sep 30, 2017 | 809,000.00 |
| Jun 30, 2017 | 757,000.00 |
| Mar 31, 2017 | 446,000.00 |
| Dec 31, 2016 | 494,000.00 |
| Sep 30, 2016 | 924,000.00 |
| Jun 30, 2016 | 1.24 Mn |
| Mar 31, 2016 | 1.65 Mn |
| Dec 31, 2015 | 1.98 Mn |
| Sep 30, 2015 | 2.35 Mn |
| Jun 30, 2015 | 2.63 Mn |
| Mar 31, 2015 | 3.05 Mn |
| Dec 31, 2014 | 723,000.00 |